News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Learn about the fundamentals of GCP and what’s new in R3 – AIEOP
AIEOP/LinkedIn
May 8, 2025, 10:58

Learn about the fundamentals of GCP and what’s new in R3 – AIEOP

AIEOP: Associazione Italiana Ematologia Oncologia Pediatrica shared a post on LinkedIn:

“Ready, Trial, Go! Operational and regulatory bases to get to the heart of clinical trials.

Introduction to GOOD CLINICAL PRACTICE (GCP) E6 (R3).

Learn about the fundamentals of GCP and what’s new in R3.

  • Webinar, May 13, 2025.
  • 2:00 p.m.-3:00 p.m.

Click here to register for the first webinar.”

Learn about the fundamentals of GCP and what's new in R3 - AIEOP

More posts featuring AIEOP.

AIEOP Associazione Italiana Ematologia Oncologia Pediatrica cancer clinical trials fight against cancer GCP Global fight against cancer Good Clinical Prcatice OncoDaily Oncology R3
Special Coverage
Voices
Aug 30, 2025, 14:18
Lauren Hamel: The Role of Nonverbal Synchrony in Race-Related Oncology Treatment Interactions
Science
Aug 30, 2025, 13:56
Survival Outcomes of Wilms' Tumor in Pediatric Patients Treated at KFMC
Voices
Aug 30, 2025, 13:50
Christopher Steer Shares ASCO Global Guideline on Geriatric Assessment
Voices
Aug 30, 2025, 13:50
Penilla Gunther on iCARE4CVD Consortium and Precision Medicine in CVD
Voices
Aug 30, 2025, 13:46
Moawia Mohammed Ali Elhassan: Jeannette Parkes - A Dedicated Leader in Radiation Oncology
Voices
Aug 30, 2025, 13:44
Ruben Mesa: Honored to Vote for the Future Ladership of the American Society of Hematology
Societies
Aug 30, 2025, 13:38
Palliative Care and Pain Management Session with Experts at AACR Conference
Insight
Aug 30, 2025, 13:34
Fellowship and Training Opportunities at POEM Group
Voices
Aug 30, 2025, 13:25
Binay Shah: Binaytara Signs MoU with the Federal Medical Center, Lagos
Societies
Aug 30, 2025, 11:47
Best of ASCO Kazakhstan 2025 Summit
Science
Aug 30, 2025, 07:12
Petros Grivas Highlights Promising TAR-200 Results in Cisplatin-Ineligible MIBC
Science
Aug 30, 2025, 06:58
Johan Pluvy Highlights ESMO 2025 NSCLC Guidelines